Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bekasi Asri Pemula Tbk (BAPA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bekasi Asri Pemula TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Bekasi Asri Pemula Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bekasi Asri Pemula Tbk trades at Rp140 (market cap 95.96B, 6.7M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Bekasi Asri Pemula Tbk is more actively traded (6.7M versus 62.5K). Which is the better fit depends on your goals.

BAPAOBAT
Market Cap
95.96B164.65B
Volume
6.7M62.5K
Lot
67.03K625
Turnover
944.4M15.03M
Average Price
140.89240.55
Value
944.4M15.03M
Indicative Equilibrium Price
140238
Indicative Equilibrium Volume
875100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BAPA
View details
OBAT
View details

About Bekasi Asri Pemula Tbk

PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.

Read more on BAPA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT